| Examination Report |
| 1 | TM-A(TRADE MARKS APPLICATION) | 24 Jan 2020 |
| 2 | Reply to Exam Report (MIS-R) | 03 Mar 2020 |
| 3 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 26 Feb 2022 |
| 4 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 07 Mar 2022 |
| 5 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 08 Mar 2022 |
| 6 | Affidavit | 07 Apr 2022 |
| 7 | Authorization Letter | 06 Sep 2022 |
| 8 | Journal Copy | 04 Jun 2024 |
| 9 | Certificate | 17 Jun 2024 |
| 1 | EXAMINATION REPORT | 9764477 | 14 Feb 2020 | |
| 2 | Hearing Notice (Show Cause) | 13902683 | 05 Aug 2022 | |
| 3 | Hearing Notice (Show Cause) | 14830227 | 21 Feb 2023 | |
| 4 | Hearing Notice (Show Cause) | 15715348 | 27 Jul 2023 | |
| 5 | Hearing Notice (Show Cause) | 16189686 | 05 Oct 2023 | |
| 6 | Hearing Notice (Show Cause) | 16806821 | 13 Dec 2023 | |
| 7 | Tribunal Accepted Notice for : 4418143 | 17180680 | 6478022 | 19 Jan 2024 |
The application for Dasapan was made on 24 January 2020.
The trademark applicant for Dasapan is Mankind Pharma Limited.
Dasapan is applied in class(es) 5.
Application for Dasapan is on Registered stage.
Application Id allotted to Dasapan is 4418143.
Trademark agent or attorney for the application is Daswani & Daswani.
Dasapan filed with the Intellectual property office as a WORD.